New PH Therapies in 2024 Pre-recorded Webinar
In March, we received news that two new therapies for the treatment of pulmonary hypertension, Opsynvi and Winrevair, were approved by the FDA. Many members of our community have reached out with questions. Will these treatments apply to me? How will they be accessible? How will these therapies change the treatment of PH?
Dr. Vallerie McLaughlin and Dr. Victor Moles of the University of Michigan took time to answer these questions and cover the basics of both drugs in our latest webinar. Watch now to learn about these new opportunities available for our PH community.
